Ashwagandha and the Thyroid: Is It Safe with Hashimoto's?

Ashwagandha (Withania somnifera) is one of the most popular adaptogens on the market, most often associated with lowering cortisol and reducing stress — we cover this in more depth in a separate article on ashwagandha and cortisol. Less often discussed is that the same plant extract has a documented, measurable effect on the thyroid axis, which for a healthy person without thyroid issues may be neutral or even beneficial, but for someone with Hashimoto's, especially already on levothyroxine, carries real clinical significance.

The popular narrative that "herbal supplements are mild and safe because they're natural" ignores the fact that biological activity doesn't depend on a substance's origin, only on its mechanism of action. For ashwagandha to affect the body at all, it must interact with hormonal systems — and since it affects the stress axis, there's no basis for assuming it remains inert toward the thyroid axis.

A trial conducted in Varanasi, India, published in the Journal of Alternative and Complementary Medicine, is one of the few to directly test ashwagandha's effect on thyroid parameters in people with subclinical hypothyroidism — TSH elevated but still within a range considered 'mild', without overt symptoms.

In people with subclinical hypothyroidism, 'improvement' in these parameters meant normalization toward the healthy range — so in this specific trial, the effect was beneficial for participants. But the same action has two sides: if ashwagandha can raise thyroid hormone production or release in someone with hypothyroidism, logically it could also, in theory, intensify symptoms in someone whose thyroid hormone levels are already sufficient or elevated through medication.

For someone with Hashimoto's on levothyroxine, the risk scenario isn't that ashwagandha directly 'harms' the thyroid, but that additional stimulation of thyroid hormone production on top of existing replacement therapy could, in theory, push results toward hyperthyroidism (excessively low TSH, elevated fT3/fT4) and trigger symptoms like heart palpitations, insomnia, or excessive nervousness. This is a theoretical scenario derived from the mechanism described in the trial, not directly tested in patients on levothyroxine — which is exactly why monitoring, not unsupervised combining, matters.

This topic illustrates well why the 'natural' label can be misleading when assessing supplement safety. Ashwagandha is genuinely biologically active — that's exactly why it affects cortisol and stress, and as this trial shows, the thyroid axis too. For most healthy people this likely isn't a problem, but for people with thyroid disease, especially those on medication, it's information worth discussing with a doctor before starting supplementation.